Tyr164
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.5.9.3
Powered by Cell Signaling Technology
Home > Phosphorylation Site Page: > Tyr164  -  CCDC86 (human)

Site Information
VPGsPEPyPGQQAPG   SwissProt Entrez-Gene
Blast this site against: NCBI  SwissProt  PDB 
Site Group ID: 18007684

In vivo Characterization
Methods used to characterize site in vivo:
mass spectrometry ( 1 , 2 )
Disease tissue studied:
cervical cancer ( 2 ) , cervical adenocarcinoma ( 2 ) , lymphoma ( 1 ) , Burkitt's lymphoma ( 1 ) , follicular lymphoma ( 1 )
Relevant cell line - cell type - tissue:

Upstream Regulation
Treatments:
nocodazole ( 2 )

References 

1

Rolland D, et al. (2014) Global phosphoproteomic profiling reveals distinct signatures in B-cell non-Hodgkin lymphomas. Am J Pathol 184, 1331-42
24667141   Curated Info

2

Olsen JV, et al. (2010) Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis. Sci Signal 3, ra3
20068231   Curated Info